FABP4 and Alzheimer disease: The experimental results showed that AD-MSCs have a stronger adipogenic differentiation capacity and produce more cellular matrix components, which may be due to the high expression of fatty acid-binding protein FABP4 in AD-MSCs compared to BM-MSCs [85].